Clinical Research Directory
Browse clinical research sites, groups, and studies.
Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy
Sponsor: Pakistan Air Force (PAF) Hospital Islamabad
Summary
Postpartum Anemia is common after childbirth and may contribute to tiredness and reduced wellbeing in mothers.This randomized controlled trial will compare two treatments for postpartum iron deficiency:intravenous ferric carboxymaltose and oral iron therapy .This study will assess whether intravenous ferric carboxymaltose provides greater improvement in maternal fatigue during the first 6 weeks after childbirth compared to oral iron.Secondary outcomes will be assessment of depressive symptoms and breastfeeding self efficacy .Eligible postpartum women with iron deficiency anemia will be randomly assigned to receive either intravenous ferric carboxymaltose or oral iron therapy and will be followed for six weeks.The study hypothesis is that intravenous ferric carboxymaltose will result in greater improvement in maternalfatigue and may also effect breastfeeding self efficacy .
Official title: Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose Versus Oral Iron Therapy
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
134
Start Date
2026-04-20
Completion Date
2026-09-20
Last Updated
2026-10-19
Healthy Volunteers
No
Conditions
Interventions
INTRAVENOUS FERRIC CARBOXYMALTOSE
Intravenous ferric carboxymaltose is administered as a single dose according to calculated iron deficit within 48hrs after postpartum
oral iron therapy
participants will receive oral ferrous sulphate tablets providing 200mg elemental iron daily till required
Locations (1)
PAF hospital islamabad
Islamabad, Punjab Province, Pakistan